Literature DB >> 15696844

Irritable bowel syndrome in general practice: an overview.

A H Oberndorff-Klein Woolthuis1, R J M Brummer, N J de Wit, J W M Muris, R W Stockbrügger.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that is frequently seen in gastroenterological practice. Population-based studies have shown that at any point in time IBS symptoms are present in about 3%-22% of the general Western population. In general practice, half of all new patients have functional disorders and IBS is responsible for about five consultations per week. General practitioners (GPs) manage the majority of IBS patients, but most knowledge (and research) is based on the smaller percentage of patients managed in secondary care. There is a paucity of literature on differences or similarities between these two groups with regard to clinical characteristics or diagnostic approach.
METHODS: The literature published in English about IBS in general practice was reviewed.
CONCLUSIONS: Irritable bowel syndrome is frequently encountered in primary care. Primary care IBS patients, compared to secondary care patients, are likely to be young, female and to have less severe symptoms. But this is only true for some symptoms; for example, non-abdominal complaints are equally reported in both groups. The disorder can be diagnosed safely using internationally agreed symptom-based criteria, such as the Rome II criteria. Additional diagnostic measures will be necessary to support the diagnosis in only a minority of situations. Many primary care IBS patients can be managed given adequate reassurance and education, frequently without additional pharmacological treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15696844     DOI: 10.1080/00855920410010942

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  7 in total

1.  Functional bowel disorders in adults.

Authors:  Winfried Häuser; Peter Layer; Peter Henningsen; Wolfgang Kruis
Journal:  Dtsch Arztebl Int       Date:  2012-02-03       Impact factor: 5.594

2.  Are Food Constituents Relevant to the Irritable Bowel Syndrome in Young Adults? - A Rome III Based Prevalence Study of the Korean Medical Students.

Authors:  Hyun Joo Jung; Moo In Park; Won Moon; Seun Ja Park; Hyung Hun Kim; Eun Ji Noh; Gyu Jin Lee; Joo Hoon Kim; Dong Gyu Kim
Journal:  J Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 4.924

3.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

4.  Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan.

Authors:  H-C Chang; A M-F Yen; J C-Y Fann; S Y-H Chiu; C-S Liao; H-H Chen; K-C Yang; L-S Chen; Y-M Lin
Journal:  Br J Cancer       Date:  2014-12-04       Impact factor: 7.640

5.  Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease.

Authors:  Antigony Mitselou; Vasileios Grammeniatis; Anna Varouktsi; Stamatis S Papadatos; Konstantinos Katsanos; Vasiliki Galani
Journal:  Intest Res       Date:  2020-01-30

6.  Factors Associated with Gastrointestinal Symptoms among Rotating Shift Nurses in South Korea: A Cross-Sectional Study.

Authors:  Sun-Kyung Hwang; Yun-Ji Lee; Min-Eun Cho; Bo-Kyoung Kim; Yea-In Yoon
Journal:  Int J Environ Res Public Health       Date:  2022-08-09       Impact factor: 4.614

7.  Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial.

Authors:  C J Bijkerk; N J de Wit; J W M Muris; P J Whorwell; J A Knottnerus; A W Hoes
Journal:  BMJ       Date:  2009-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.